review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0376-8716(98)00077-5 |
P698 | PubMed publication ID | 9716941 |
P2093 | author name string | Daly JW | |
Fredholm BB | |||
P2860 | cites work | Effect of long term caffeine treatment on A1 and A2 adenosine receptor binding and on mRNA levels in rat brain | Q48306365 |
Caffeine mimics the effect of a dopamine D2/3 receptor agonist on the expression of immediate early genes in globus pallidus | Q48597332 | ||
Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression. | Q48620855 | ||
Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas | Q48624366 | ||
A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. | Q48658263 | ||
Regulation of muscarinic acetylcholine receptor-mediated synaptic responses by adenosine receptors in the rat hippocampus | Q48669709 | ||
Desensitisation of the adenosine A1 receptor by the A2A receptor in the rat striatum | Q48677147 | ||
Caffeine exposure sensitizes rats to the reinforcing effects of cocaine | Q48806782 | ||
Opposing actions of adenosine A2a and dopamine D2 receptor activation on GABA release in the basal ganglia: evidence for an A2a/D2 receptor interaction in globus pallidus | Q49133941 | ||
Reinstatement of extinguished cocaine-taking behavior by cocaine and caffeine. | Q51635374 | ||
Nicotine and caffeine use in cocaine-dependent individuals. | Q51675464 | ||
Tolerance to oral and IP caffeine: locomotor activity and pharmacokinetics. | Q52216253 | ||
Tolerance to behavioral effects of caffeine in rats | Q52252655 | ||
Nicotine, caffeine and alcohol use in high- and low-dose benzodiazepine users. | Q52275176 | ||
The role of adenosine A2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons | Q70872883 | ||
Caffeine-induced expression of c-fos mRNA and NGFI-A mRNA in caudate putamen and in nucleus accumbens are differentially affected by the N-methyl-D-aspartate receptor antagonist MK-801 | Q71284259 | ||
Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration | Q71511637 | ||
Adenosine A1 receptor-dopamine D1 receptor interaction in the rat limbic system: modulation of dopamine D1 receptor antagonist binding sites | Q71660122 | ||
Neuroleptics Up‐Regulate Adenosine A2a Receptors in Rat Striatum: Implications for the Mechanism and the Treatment of Tardive Dyskinesia | Q71832422 | ||
Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction | Q72389944 | ||
D1 and D2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats | Q72669780 | ||
Caffeine and nicotine: a review of their joint use and possible interactive effects in tobacco withdrawal | Q72759048 | ||
Caffeine reinforcement: the role of withdrawal | Q73359149 | ||
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor | Q24323906 | ||
Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes | Q24563287 | ||
Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens | Q34432262 | ||
Adenosine-dopamine interactions in the brain | Q35661950 | ||
Adenosine receptor ligands: differences with acute versus chronic treatment | Q36200374 | ||
Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain | Q36219734 | ||
Locomotor activity in mice during chronic treatment with caffeine and withdrawal. | Q36570404 | ||
Adenosine inhibition of mesopontine cholinergic neurons: implications for EEG arousal | Q36729270 | ||
Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms | Q36813798 | ||
Caffeine as a model drug of abuse | Q37989593 | ||
Discriminative stimulus and subjective effects of theobromine and caffeine in humans. | Q38571902 | ||
How does adenosine inhibit transmitter release? | Q39473010 | ||
Reinforcing properties of caffeine: studies in humans and laboratory animals | Q39638369 | ||
Pharmacology of adenosine A2A receptors | Q41287901 | ||
The Role of Dopamine in the Behavioral Effects of Caffeine in Animals and Humans | Q41527844 | ||
Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease | Q41622546 | ||
Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia | Q41624006 | ||
Immunohistochemical detection of A1 adenosine receptors in rat brain with emphasis on localization in the hippocampal formation, cerebral cortex, cerebellum, and basal ganglia | Q42478257 | ||
Adenosine A1 receptor blockade selectively potentiates the motor effects induced by dopamine D1 receptor stimulation in rodents | Q42527647 | ||
Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. | Q42545166 | ||
Caffeine-induced place and taste conditioning: production of dose-dependent preference and aversion | Q43681421 | ||
Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. | Q48152835 | ||
P433 | issue | 1-2 | |
P304 | page(s) | 199-206 | |
P577 | publication date | 1998-06-01 | |
P1433 | published in | Drug and Alcohol Dependence | Q5308875 |
P1476 | title | Caffeine--an atypical drug of dependence | |
P478 | volume | 51 |
Q46736722 | A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors |
Q27312296 | A review of pharmacogenetic studies of substance-related disorders |
Q28680729 | A unified framework for addiction: vulnerabilities in the decision process |
Q46937750 | Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice |
Q34122531 | Adenosine A1 and A2A receptors are not upstream of caffeine's dopamine D2 receptor-dependent aversive effects and dopamine-independent rewarding effects |
Q46657371 | Adenosine A1 receptors inhibit GABAergic transmission in rat tuberomammillary nucleus neurons |
Q34628537 | Adenosine A1, but not A2, receptor blockade increases anxiety and arousal in Zebrafish. |
Q30384658 | Adenosine Receptors: The Contributions by John W. Daly. |
Q36083482 | Adenosine and brain function |
Q35063214 | Adenosine receptors in the nervous system: pathophysiological implications. |
Q34041843 | Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state. |
Q24635635 | Alcohol, nicotine, caffeine, and mental disorders |
Q33933548 | Alteration of the behavioral effects of nicotine by chronic caffeine exposure. |
Q37350588 | Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety |
Q35759035 | Association of ADORA1 rs2228079 and ADORA2A rs5751876 Polymorphisms with Gilles de la Tourette Syndrome in the Polish Population. |
Q40089085 | Associations of coffee genetic risk scores with consumption of coffee, tea and other beverages in the UK Biobank |
Q42494485 | Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in vivo microdialysis study |
Q46485293 | Caffeine and headaches |
Q34448791 | Caffeine and stress: implications for risk, assessment, and management of hypertension |
Q37222131 | Caffeine dose effect on activation-induced BOLD and CBF responses |
Q44085141 | Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens |
Q37599450 | Caffeine inhibits cell proliferation and regulates PKA/GSK3β pathways in U87MG human glioma cells |
Q44541546 | Caffeine raises the serum melatonin level in healthy subjects: an indication of melatonin metabolism by cytochrome P450(CYP)1A2. |
Q48164855 | Caffeine restores regional brain activation in acute hypoglycaemia in healthy volunteers |
Q24642453 | Caffeine stimulation of cortisol secretion across the waking hours in relation to caffeine intake levels |
Q33919329 | Caffeine's Attenuation of Cocaine-Induced Dopamine Release by Inhibition of Adenosine |
Q47422595 | Caffeine, a common active adulterant of cocaine, enhances the reinforcing effect of cocaine and its motivational value |
Q34088937 | Caffeine, cognitive functioning, and white matter lesions in the elderly: establishing causality from epidemiological evidence. |
Q73302947 | Central adenosine A(2A) receptors: an overview |
Q33954408 | Chronic caffeine ingestion causes microglia activation, but not proliferation in the healthy brain |
Q33871678 | Chronic effects of xanthines on levels of central receptors in mice |
Q45368915 | Cocaine and Caffeine Effects on the Conditioned Place Preference Test: Concomitant Changes on Early Genes within the Mouse Prefrontal Cortex and Nucleus Accumbens |
Q33894614 | Could a common biochemical mechanism underlie addictions? |
Q58551486 | Craving espresso: the dialetics in classifying caffeine as an abuse drug |
Q48159056 | Decision-making style, nicotine and caffeine use and dependence |
Q44028209 | Dicinnamoylquinides in roasted coffee inhibit the human adenosine transporter |
Q105160254 | Dioicine: A Novel Prenylated Purine Alkaloid from Gymnocladus dioicus |
Q22254619 | Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects |
Q28572671 | Effects of an adenosine A2A receptor blockade in the nucleus accumbens on locomotion, feeding, and prepulse inhibition in rats |
Q42481687 | Effects of aripiprazole on caffeine-induced hyperlocomotion and neural activation in the striatum |
Q33961140 | Effects of caffeine on human behavior |
Q44660000 | Evidence for the role of nitric oxide in caffeine-induced locomotor activity in mice. |
Q31863493 | Facilitative effects of an adenosine A1/A2 receptor blockade on spatial memory performance of rats: selective enhancement of reference memory retention during the light period |
Q36071808 | Genetic factors modulating the response to stimulant drugs in humans |
Q34119748 | Genetics of caffeine consumption and responses to caffeine |
Q51435593 | Habitual coffee and tea drinkers experienced increases in blood pressure after consuming low to moderate doses of caffeine; these increases were larger upright than in the supine posture. |
Q45958705 | Influence of acute caffeine on 50-kHz ultrasonic vocalizations in male adult rats and relevance to caffeine-mediated psychopharmacological effects. |
Q34191271 | Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration |
Q45254536 | Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats |
Q36664847 | Is caffeine addictive?--a review of the literature |
Q36969254 | Laurate Biosensors Image Brain Neurotransmitters In Vivo: Can an Antihypertensive Medication Alter Psychostimulant Behavior? |
Q37791061 | Methylxanthines and Drug Dependence: A Focus on Interactions with Substances of Abuse |
Q44112620 | Mice lacking the adenosine A1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate |
Q46835111 | Modulation of 3',5'-cyclic AMP homeostasis in human platelets by coffee and individual coffee constituents |
Q35668357 | Neuroadaptations in adenosine receptor signaling following long-term ethanol exposure and withdrawal. |
Q22241711 | Neuropsychiatric effects of caffeine |
Q36163189 | New insights into the regulation of synaptic plasticity from an unexpected place: hippocampal area CA2. |
Q48400898 | Nitric oxide production in the basal forebrain is required for recovery sleep |
Q41457950 | Orexin A attenuates the sleep-promoting effect of adenosine in the lateral hypothalamus of rats |
Q30855196 | Perinatal caffeine, acting on maternal adenosine A(1) receptors, causes long-lasting behavioral changes in mouse offspring |
Q48498126 | Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons |
Q33794389 | Presence of caffeine reversibly interferes with efficacy of acupuncture-induced analgesia |
Q47222005 | Purinergic Signaling in Mast Cell Degranulation and Asthma |
Q28295045 | Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory |
Q39162731 | Regulation of intestinal hPepT1 (SLC15A1) activity by phosphodiesterase inhibitors is via inhibition of NHE3 (SLC9A3) |
Q33741040 | Sex differences in caffeine neurotoxicity following chronic ethanol exposure and withdrawal |
Q36466181 | Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists. |
Q39430303 | Synergistic antidepressant-like effect of the joint administration of caffeine and NMDA receptor ligands in the forced swim test in mice |
Q44595559 | The Effect of Caffeine on Peripheral Vascular Resistance in Isolated Perfused Guinea Pig Hind Limbs |
Q50099594 | The Effects of Carbohydrates, in Isolation and Combined with Caffeine, on Cognitive Performance and Mood-Current Evidence and Future Directions. |
Q39403626 | The Taste of Caffeine |
Q38875939 | The abuse liability of the NMDA receptor antagonist-benzodiazepine (tiletamine-zolazepam) combination: evidence from clinical case reports and preclinical studies |
Q48371280 | The association between caffeine and cognitive decline: examining alternative causal hypotheses. |
Q45293246 | The effects of caffeine and expectancy on attention and memory |
Q46727973 | The influence of different food and drink on tics in Tourette syndrome |
Q42371156 | The interoceptive Pavlovian stimulus effects of caffeine |
Q47749270 | The perinatal effects of maternal caffeine intake on fetal and neonatal brain levels of testosterone, estradiol, and dihydrotestosterone in rats |
Q37200611 | Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A 2A receptor knockout mice with microarray profiling |
Q34804523 | Update on caffeine consumption, disposition and action |